A recently published letter in The Lancet, signed by Dr. Juan Fortea and leading European experts in Alzheimer’s disease, celebrates the European Commission’s approval of lecanemab as a key milest...
An international team of researchers has discovered how cholesterol can disrupt the internal functioning of the heart by accumulating in the mitochondria of cardiomyocytes. They have also developed an...
The Sant Pau Research Institute (IR Sant Pau) presented its new Strategic Plan 2025-2030 this Tuesday, in an event open to all research and healthcare staff. The plan will define the...
A recent study has identified specific alterations in lipid metabolism associated with subclinical atherosclerosis in individuals with type 2 diabetes. This silent condition, known as atherosclerosis,...
Intravenous administration of atorvastatin during acute myocardial infarction could become a new therapeutic strategy capable of limiting infarct size in patients with diabetic cardiomyopathy, a heart...
